Buck Wealth Strategies’s abrdn Life Sciences Investors HQL Stock Holding History

Buck Wealth Strategies’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.9K	Buy	+697	New	+$12.3K	﹤0.01%	539
2023 Q4	–	Sell	-493	Closed	-$6.15K	–	177
2023 Q3	$6.15K	Buy	493 +12	+2%	+$158	﹤0.01%	226
2023 Q2	$6.51K	Buy	481 +11	+2%	+$152	﹤0.01%	170
2023 Q1	$6.55K	Buy	+470	New	+$6.72K	﹤0.01%	121

Other funds holding HQL

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Buck Wealth Strategies's HQL Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in abrdn Life Sciences Investors (HQL) in Q2 2026: 697 shares worth $13.9K. The stake represents ﹤0.01% of the portfolio and ranks #539 among its holdings. This is a return to the name: Buck Wealth Strategies previously reported a position in HQL as recently as Q3 2023.

Buck Wealth Strategies first reported a position in HQL in Q1 2023 and has held it in 4 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

Buck Wealth Strategies held 697 shares of abrdn Life Sciences Investors worth $13.9K as of Q2 2026.
abrdn Life Sciences Investors was a new Buck Wealth Strategies position in Q2 2026.
abrdn Life Sciences Investors made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #539 holding.
Buck Wealth Strategies first reported a position in abrdn Life Sciences Investors in Q1 2023 and has held it in 4 quarters since.
83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.